Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hospital of ChinaHKSE:03869 73 EV-to-FCF is 6.86 as of Sep. 01, 2026, which is 77% below its 10-year median of 30.04. GuruFocus rates HKSE:03869 with a GF Score™ of 73/100 and a GF Value™ of HK$5.53 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 420 Healthcare Providers & Services companies, Hospital of China ranks better than 84.05% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Hospital of China's Enterprise Value is HK$1,026 Mil.
Hospital of China's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$150 Mil. Therefore, Hospital of China's EV-to-FCF for today is 6.86.
The historical rank and industry rank for Hospital of China's EV-to-FCF or its related term are showing as below:
HKSE:03869'
s EV-to-FCF Range Over the Past 10 Years
Min: 5.78 Med: 30.04 Max: 67.12
Current: 6.86
During the past 12 years, the highest EV-to-FCF of Hospital of China was 67.12. The lowest was 5.78. And the median was 30.04.
HKSE:03869's EV-to-FCF is ranked better than 84.05% of 420
companies
in the Healthcare Providers & Services industry
Industry Median: 18.735
vs HKSE:03869: 6.86
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hospital of China (HKSE:03869) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hospital of China's PE Ratio (TTM) for today is calculated as:
Hospital of China's share price for today is HK$3.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hospital of China's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.407.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Hospital of China EV-to-FCF Related Terms
Hospital of China EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Hospital of China's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Hospital of China's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital of China EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital of China's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Hospital of China's EV-to-FCF falls into.
Hospital of China's current Enterprise Value is HK$1,026 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hospital of China's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$150 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hospital of China (HKSE:03869) has a EV-to-FCF of 6.86 as of Sep. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Hospital of China and its competitors. This is 77% below median its historical median of 30.04. Over the past decade, Hospital of China's EV-to-FCF has ranged from 5.78 to 67.12. According to the industry distribution chart, Hospital of China ranks #67 out of 420 companies in the Healthcare Providers & Services industry, placing it in the top 16%.
Is Hospital of China's EV-to-FCF too high?
Hospital of China's current EV-to-FCF of 6.86 is 77% below median its 10-year median of 30.04. Over the past 10 years, this metric has ranged from a low of 5.78 to a high of 67.12. The Healthcare Providers & Services industry median EV-to-FCF is 18.74. Hospital of China's value of 6.86 is 63.4% below this industry median. Based on the distribution chart, Hospital of China ranks #67 out of 420 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Hospital of China has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hospital of China's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital of China ranks #67 out of 420 companies for EV-to-FCF. This places Hospital of China in the top 16% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 18.74. Hospital of China's value of 6.86 is 63.4% below this benchmark. Historically, Hospital of China's own EV-to-FCF has ranged from 5.78 to 67.12 over the past decade. While the company's 10-year median is 30.04 vs. the industry median of 18.74, Hospital of China has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.74, based on 420 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital of China's current EV-to-FCF of 6.86 is 63.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Hospital of China and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital of China's current EV-to-FCF is 6.86, which is 77% below median its own 10-year median of 30.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital of China stock overvalued right now?
Based on GuruFocus' analysis, Hospital of China (HKSE:03869) is currently considered Possible Value Trap. The stock's GF Value™ is HK$5.53, compared to a current price of HK$3.40 — trading 38.5% below its estimated fair value. The current EV-to-FCF is 6.86, which is 77% below median its 10-year median of 30.04 and 63.4% below the Healthcare Providers & Services industry median of 18.74. Hospital of China's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Hospital of China (HKSE:03869), the current EV-to-FCF is 6.86 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital of China (HKSE:03869) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital of China stock appears to be undervalued.
The current stock price of HK$3.40 is trading 38.5% below its estimated GF Value™ of HK$5.53.
GuruFocus considers Hospital of China to be Possible Value Trap.
Key valuation signals for HKSE:03869:
EV-to-FCF: 6.86 (77% below median its 10-year median of 30.04)
GF Value™: HK$5.53 vs. price of HK$3.40 (38.5% below fair value)
Industry Position: 63.4% below the Healthcare Providers & Services median (#67 of 420)
No single metric tells the full story. See the HKSE:03869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Corporation of China Ltd is an investment holding company that operates and manages hospitals in the People's Republic of China. In addition to offering hospital management services, it also provides supply chain services, other ancillary services, and sells pharmaceutical products. The company has three operating segments, namely, Hospital management services, General hospital services, and the sale of pharmaceutical products. The General Hospital services segment is the primary revenue generator for the company. All the company's revenue is generates from PRC.
73GF Score
Get the complete analysis for HKSE:03869
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:03869 has been successfully added to your 
